A recent study found that aspirin therapy administered to patients with ARDS was associated with a reduced risk of ICU mortality.
Acute respiratory distress syndrome (ARDS) is a common clinical syndrome with high mortality and long-term morbidity. To date there is no effective pharmacological therapy.
Aspirin therapy has recently been shown to reduce the risk of developing ARDS, but the effect of aspirin on established ARDS is unknown.
Using multivariate logistic regression analysis, aspirin therapy, given either before or during hospital stay, was associated with a reduction in ICU mortality. Additional factors that predicted ICU mortality for patients with ARDS were vasopressor use and APACHE II score.